A recent study published in Archivos Españoles de Urologia, validates marked results of effectiveness and safety of LIESWT on patients with ED who have failed to respond to PDE5i treatment. Drs. Bechara, Casabe, De Bonis and Nazar from Buenos Aires Argentina , conclude that over 50% reacted positively to the treatment restoring patient's PDE5i response.

About DirexGroup:
DirexGroup specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established nearly 30 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assure competent support and maintenance. Contact DirexGroup at: This email address is being protected from spambots. You need JavaScript enabled to view it.